Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hematologic Neoplasms 3Neoplasms, Plasma Cell 2Lymphoma 2Leukemia 2Infections 2Waldenstrom Macroglobulinemia 1Urinary Tract Infections 1Staphylococcal Infections 1Spasm 1Sleep Initiation and Maintenance Disorders 1Sepsis 1Seizures 1Schizophrenia, Treatment-Resistant 1Schizophrenia 1Retinitis 1Renal Insufficiency, Chronic 1Recurrence 1Pulmonary Arterial Hypertension 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pneumonia 1Pancreatic Neoplasms 1Pancreatic Diseases 1Pain 1Other Infectious Diseases 1Neutropenia 1Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Migraine Disorders 1

Interventions

Gemcitabine 7130-nm albumin-bound paclitaxel 5Albumin-Bound Paclitaxel 4napabucasin 2Paclitaxel 2MK-4721 2Irinotecan 2irinotecan sucrosofate 1Taxes 1Piperacillin, Tazobactam Drug Combination 1Oxaliplatin 1Ocoxin 1Needles 1Leucovorin 1HhAntag691 1Fluorouracil 1Duodenoscopes 1Cisplatin 1Cefoxitin 1Capecitabine 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Pancreatic Diseases × Piperacillin, Tazobactam Drug Combination × Clear all
NCT03269994 2025-10-21

Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?

Memorial Sloan Kettering Cancer Center

Phase 3 Completed
967 enrolled 9 charts
Gastrointestinal

Pancreatic Diseases, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡